X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
oncology (20) 20
humans (19) 19
female (18) 18
index medicus (17) 17
middle aged (17) 17
prognosis (15) 15
adult (14) 14
aged (14) 14
breast cancer (13) 13
cancer (12) 12
immunohistochemistry (12) 12
expression (11) 11
pathology (9) 9
aged, 80 and over (8) 8
breast neoplasms - metabolism (7) 7
disease-free survival (7) 7
metastasis (7) 7
tumors (7) 7
analysis (6) 6
breast neoplasms - drug therapy (6) 6
breast neoplasms - pathology (6) 6
chemotherapy (6) 6
cooperative oncology group (6) 6
kaplan-meier estimate (6) 6
medical research (6) 6
patients (6) 6
proteins (6) 6
antineoplastic agents - therapeutic use (5) 5
erbb-2 protein (5) 5
genes (5) 5
hospitals (5) 5
laboratories (5) 5
male (5) 5
medical prognosis (5) 5
medicine (5) 5
multidisciplinary sciences (5) 5
protein expression (5) 5
risk (5) 5
science (5) 5
young adult (5) 5
biology and life sciences (4) 4
biomarkers (4) 4
breast (4) 4
breast neoplasms - diagnosis (4) 4
carcinoma (4) 4
case-control studies (4) 4
cell biology (4) 4
clinical trials (4) 4
dense sequential chemotherapy (4) 4
epirubicin (4) 4
estrogen (4) 4
gene (4) 4
gene expression (4) 4
medicine and health sciences (4) 4
multivariate analysis (4) 4
mutation (4) 4
randomized phase-iii (4) 4
receptors, estrogen - metabolism (4) 4
recommendations (4) 4
research article (4) 4
retrospective studies (4) 4
survival (4) 4
amplification (3) 3
breast neoplasms - mortality (3) 3
breast tumors (3) 3
cancer patients (3) 3
cancer therapies (3) 3
cancer treatment (3) 3
cancers and neoplasms (3) 3
colorectal cancer (3) 3
epidermal growth factor receptors (3) 3
genotype (3) 3
greece (3) 3
health sciences (3) 3
her2 (3) 3
metastases (3) 3
mortality (3) 3
mutations (3) 3
neoplasm staging (3) 3
overexpression (3) 3
p53 protein (3) 3
paclitaxel (3) 3
paraffin (3) 3
prospective studies (3) 3
receptor, erbb-2 - metabolism (3) 3
receptors (3) 3
receptors, progesterone - metabolism (3) 3
research (3) 3
research and analysis methods (3) 3
skin and connective tissue diseases (3) 3
subgroups (3) 3
survival analysis (3) 3
therapy (3) 3
tissue microarrays (3) 3
trastuzumab (3) 3
treatment outcome (3) 3
1506 (2) 2
adenocarcinoma (2) 2
adenocarcinoma - metabolism (2) 2
adenocarcinoma - mortality (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 06/2012, Volume 7, Issue 6, p. e37946
Background: The aim of the present study was to investigate the efficacy of adjuvant dose-dense sequential chemotherapy with epirubicin, paclitaxel, and CMF in... 
PHASE-III TRIAL | COOPERATIVE ONCOLOGY GROUP | NEOADJUVANT CHEMOTHERAPY | MULTIDISCIPLINARY SCIENCES | PROTEIN EXPRESSION | TISSUE MICROARRAYS | BRAIN METASTASES | RISK | DENSE SEQUENTIAL CHEMOTHERAPY | PROGNOSTIC VALUE | DOCETAXEL | Immunohistochemistry | Receptors, Estrogen - metabolism | Humans | Middle Aged | Receptor, ErbB-2 - metabolism | Methotrexate - therapeutic use | Breast Neoplasms - drug therapy | Paclitaxel - therapeutic use | Cyclophosphamide - therapeutic use | Breast Neoplasms - metabolism | Receptors, Progesterone - metabolism | Young Adult | Disease-Free Survival | Fluorouracil - therapeutic use | Receptor, Epidermal Growth Factor - metabolism | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Chemotherapy, Adjuvant - methods | Epirubicin - therapeutic use | Keratin-5 - metabolism | Adult | Female | Aged | Anthracyclines - therapeutic use | Medical research | Anthracyclines | Estrogen | Adjuvant treatment | Breast cancer | Metastasis | Keratin | Paclitaxel | Medicine, Experimental | Rankings | Progesterone | Health aspects | Cancer | Enrichment | Brain | Cytokeratin | Laboratories | Liver | Estrogens | Clinical trials | Estrogen receptors | Oncology | Nervous system | Paraffin | Cancer therapies | Subgroups | Metastases | Proteins | Cell growth | Mastectomy | Epirubicin | Drug dosages | Risk groups | Epidermal growth factor receptors | Health risks | Patients | Survival | ErbB-2 protein | Medicine | Studies | Pathology | Chemotherapy | Brain research | Hospitals | Anthracycline | Collaboration | Medical prognosis | Biomarkers | Trastuzumab | Tumors
Journal Article
PLoS ONE, ISSN 1932-6203, 12/2018, Volume 13, Issue 12, p. e0207707
Journal Article
International Journal of Cancer, ISSN 0020-7136, 01/2018, Volume 142, Issue 1, pp. 66 - 80
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 08/2017, Volume 12, Issue 8, p. e0180489
Background-Aim To evaluate the prognostic role of elaborate molecular clusters encompassing cyclin D1, cyclin E1, p21, p27 and p53 in the context of various... 
OVEREXPRESSION | COOPERATIVE ONCOLOGY GROUP | PROGNOSTIC-FACTOR | EPIRUBICIN | RANDOMIZED PHASE-III | MULTIDISCIPLINARY SCIENCES | DENSE SEQUENTIAL CHEMOTHERAPY | INHIBITORS | P21 | P27(KIP1) | Immunohistochemistry | Prognosis | Cyclin-Dependent Kinase Inhibitor p27 - analysis | Humans | Middle Aged | Antineoplastic Agents - therapeutic use | Triple Negative Breast Neoplasms - drug therapy | Breast Neoplasms - drug therapy | Young Adult | Cyclin D1 - analysis | Tumor Suppressor Protein p53 - analysis | Cyclin-Dependent Kinase Inhibitor p21 - analysis | Breast - drug effects | Breast Neoplasms - pathology | Triple Negative Breast Neoplasms - diagnosis | Cyclin E - analysis | Survival Analysis | Triple Negative Breast Neoplasms - pathology | Adult | Female | Aged | Breast Neoplasms - diagnosis | Oncogene Proteins - analysis | Breast - pathology | Usage | Analysis | Cell cycle | Clinical trials | Breast cancer | Research | Health sciences | GTP-binding protein | Regulators | Laboratories | Molecular clusters | p53 Protein | Oncology | Paraffin | Cyclin D1 | Kinases | Tissues | Cancer therapies | Formaldehyde | Cell adhesion & migration | Proteins | Medical research | Cyclin-dependent kinases | Clustering | Medicine | Pathology | Cyclin-dependent kinase inhibitor p21 | Hospitals | Medical prognosis | Breast | Tumors | Cancer | Apoptosis
Journal Article
PLoS ONE, ISSN 1932-6203, 03/2014, Volume 9, Issue 3, p. e91407
Journal Article
Cancer genomics & proteomics, ISSN 1109-6535, 11/2018, Volume 15, Issue 6, pp. 461 - 471
Journal Article